First Patients Dosed in Phase 2 Test of Lynovex for CF Exacerbations
cystic fibrosis, News
The first patients have been dosed in the Phase 2 clinical trial evaluating NovaBiotics‘ Lynovex (NM001, cysteamine) as an adjunct therapy for infectious exacerbations in cystic fibrosis (CF). CARE-CF ... Read more